ZA200306383B - Pharmaceutical formulation comprising bicalutamide. - Google Patents

Pharmaceutical formulation comprising bicalutamide.

Info

Publication number
ZA200306383B
ZA200306383B ZA200306383A ZA200306383A ZA200306383B ZA 200306383 B ZA200306383 B ZA 200306383B ZA 200306383 A ZA200306383 A ZA 200306383A ZA 200306383 A ZA200306383 A ZA 200306383A ZA 200306383 B ZA200306383 B ZA 200306383B
Authority
ZA
South Africa
Prior art keywords
bicalutamide
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
ZA200306383A
Inventor
Nicola Bateman
Julie Cahill
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200306383B publication Critical patent/ZA200306383B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200306383A 2001-02-27 2003-08-15 Pharmaceutical formulation comprising bicalutamide. ZA200306383B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0104749A GB2372444A (en) 2001-02-27 2001-02-27 A pharmaceutical formulation comprising bicalutamide and a hydroxypropylmethylcellulose polymer

Publications (1)

Publication Number Publication Date
ZA200306383B true ZA200306383B (en) 2004-11-15

Family

ID=9909542

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200306383A ZA200306383B (en) 2001-02-27 2003-08-15 Pharmaceutical formulation comprising bicalutamide.

Country Status (2)

Country Link
GB (1) GB2372444A (en)
ZA (1) ZA200306383B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06008520A (en) * 2004-01-28 2008-02-13 Androscience Corp Enhancement of anti-androgenic activity by a combination of inhibitors targeting different steps of a steroid-dependent gene activation pathway and uses thereof.
DE202006000585U1 (en) * 2006-01-13 2007-05-24 Wanzl Metallwarenfabrik Gmbh Shelf divider system comprises grids mounted transversely on shelves which are held in place by clips fitting over rim of lip on front of shelf

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083532A (en) * 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom
AU5925399A (en) * 1998-09-16 2000-04-03 Oncopharmaceutical, Inc. Treatment of oncologic tumors with an injectable formulation of a golgi apparatus disturbing agent

Also Published As

Publication number Publication date
GB0104749D0 (en) 2001-04-18
GB2372444A (en) 2002-08-28

Similar Documents

Publication Publication Date Title
MXPA03006884A (en) Pharmaceutical formulation.
HUP0302847A3 (en) Pharmaceutical formulation comprising bicalutamide
MXPA03007215A (en) Pharmaceutical formulations.
GB0118689D0 (en) Pharmaceutical formulation
AP2003002907A0 (en) Liquid pharmaceutical composition.
PL366432A1 (en) Pharmaceutical formulation
GB0121715D0 (en) Pharmaceutical formulations
ZA200206779B (en) Solid formulation.
IL161902A0 (en) Pharmaceutical formulation comprising bicalutamide
GB0120701D0 (en) Pharmaceutical formulations
GB0103638D0 (en) Pharmaceutical formulations
GB2380129B (en) Pharmaceutical formulations
ZA200402729B (en) Pharmaceutical formulation comprising (R) -bicalutamide.
GB0105560D0 (en) Pharmaceutical formulations
GB0125492D0 (en) Formulation
ZA200306383B (en) Pharmaceutical formulation comprising bicalutamide.
ZA200110500B (en) Pharmaceutical composition.
MXPA03007318A (en) Pharmaceutical composition.
GB0124455D0 (en) Pharmaceutical formulations
GB2396812B (en) Formulation
GB2375048B (en) Formulation
ZA200110501B (en) Pharmaceutical composition.
ZA200402731B (en) Pharmaceutical formulation.
GB0116619D0 (en) Formulation
ZA200110499B (en) Pharmaceutical composition.